Artwork

Contenu fourni par CITI Program. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par CITI Program ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast

49:31
 
Partager
 

Manage episode 425582715 series 3435518
Contenu fourni par CITI Program. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par CITI Program ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Join us for a thoughtful, long-form discussion about the evolving IRB Industry. Julie Blasingim, the CEO of Univo IRB, sits down to talk about how we got to the current IRB landscape we have now, and the future of IRBs. She covers a lot of areas related to the IRB, including how for-profit IRBs balance ethical reviews with the economics of business, identifying the gap between patients and the IRB process, as well as some hot topics for the IRB, like growing privacy protection concerns and the impact of AI on the IRB process.
Additional Resources:

Guest Bio: Julie Blasingim, CEO of Univo IRB, is a seasoned IRB executive with 20 years of extensive regulatory, operational, and compliance experience in human research protection and site operations of clinical research. She has served in a dozen senior leadership roles across multiple central IRBs, has hosted countless FDA inspections at both the IRB and under-site operations, and has managed multiple accreditations and certifications through AAHRPP and ISO. Julie holds a master’s degree in business administration specializing in leadership.

  continue reading

Chapitres

1. The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast (00:00:00)

2. Introduction to Julie Blasingim (00:01:02)

3. Julie's Journey into the Research Industry (00:01:42)

4. Evolution of Independent IRBs (00:03:02)

5. IRB Landscape Changes (00:07:09)

6. Managing Ethical Concerns in For-Profit (00:15:30)

7. Disconnect Between IRBs and Patients (00:19:54)

8. IRBs' Unique Position (00:23:45)

9. Patient-Centric Approach (00:24:46)

10. IRBs' Evolution (00:26:14)

11. Ethical Concerns in Research (00:28:29)

12. IT Security and IRB Boards (00:31:22)

13. AI Impact on IRBs (00:33:52)

14. Ethical Framework and Decision-Making (00:40:10)

15. Balancing Risk and Patient Empowerment (00:43:09)

16. Same Team: Impactful Research (00:46:37)

17. Closing Remarks (00:48:57)

25 episodes

Artwork
iconPartager
 
Manage episode 425582715 series 3435518
Contenu fourni par CITI Program. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par CITI Program ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Join us for a thoughtful, long-form discussion about the evolving IRB Industry. Julie Blasingim, the CEO of Univo IRB, sits down to talk about how we got to the current IRB landscape we have now, and the future of IRBs. She covers a lot of areas related to the IRB, including how for-profit IRBs balance ethical reviews with the economics of business, identifying the gap between patients and the IRB process, as well as some hot topics for the IRB, like growing privacy protection concerns and the impact of AI on the IRB process.
Additional Resources:

Guest Bio: Julie Blasingim, CEO of Univo IRB, is a seasoned IRB executive with 20 years of extensive regulatory, operational, and compliance experience in human research protection and site operations of clinical research. She has served in a dozen senior leadership roles across multiple central IRBs, has hosted countless FDA inspections at both the IRB and under-site operations, and has managed multiple accreditations and certifications through AAHRPP and ISO. Julie holds a master’s degree in business administration specializing in leadership.

  continue reading

Chapitres

1. The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast (00:00:00)

2. Introduction to Julie Blasingim (00:01:02)

3. Julie's Journey into the Research Industry (00:01:42)

4. Evolution of Independent IRBs (00:03:02)

5. IRB Landscape Changes (00:07:09)

6. Managing Ethical Concerns in For-Profit (00:15:30)

7. Disconnect Between IRBs and Patients (00:19:54)

8. IRBs' Unique Position (00:23:45)

9. Patient-Centric Approach (00:24:46)

10. IRBs' Evolution (00:26:14)

11. Ethical Concerns in Research (00:28:29)

12. IT Security and IRB Boards (00:31:22)

13. AI Impact on IRBs (00:33:52)

14. Ethical Framework and Decision-Making (00:40:10)

15. Balancing Risk and Patient Empowerment (00:43:09)

16. Same Team: Impactful Research (00:46:37)

17. Closing Remarks (00:48:57)

25 episodes

Tous les épisodes

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide